Literature DB >> 20124567

Emergency department presentation of ketamine abusers in Hong Kong: a review of 233 cases.

S H Ng1, M L Tse, H W Ng, F L Lau.   

Abstract

OBJECTIVES: To study the acute clinical presentations of ketamine abusers in Hong Kong.
DESIGN: Retrospective chart review.
SETTING: Fifteen accident and emergency departments in Hong Kong. PATIENTS: Consultations associated with recent ketamine use either confirmed by history or urine test were searched for from the database of the Hospital Authority Hong Kong Poison Information Centre from 1 July 2005 to 30 June 2008. Their medical records and investigation results were analysed.
RESULTS: A total of 233 records of ketamine use were included for review. Patient ages ranged from 13 to 60, with a median of 22 years, and the male-to-female ratio being 2.1:1. The most common symptoms of ketamine misuse were impaired consciousness (45%), abdominal pain (21%), lower urinary tract symptoms (12%), and dizziness (12%). The most common abnormal physical findings were high blood pressure (40%), followed by tachycardia (39%), abdominal tenderness (18%), and white powder in the nostrils (17%).
CONCLUSION: Most ketamine abusers presented acutely with transient central nervous system depression, abdominal pain, or lower urinary tract symptoms. Clinicians should be alert to the typical age-group, signs and symptoms of such abusers presenting in an acute medical setting.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20124567

Source DB:  PubMed          Journal:  Hong Kong Med J        ISSN: 1024-2708            Impact factor:   2.227


  24 in total

1.  Individual and peer factors associated with ketamine use among adolescents in Taiwan.

Authors:  Kun-Hua Lee; Yi-Chun Yeh; Pin-Chen Yang; Huang-Chi Lin; Peng-Wei Wang; Tai-Ling Liu; Cheng-Fang Yen
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-06-22       Impact factor: 4.785

2.  Acute and chronic toxicity pattern in ketamine abusers in Hong Kong.

Authors:  Chan Yiu-Cheung
Journal:  J Med Toxicol       Date:  2012-09

Review 3.  Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.

Authors:  Mark J Niciu; Ioline D Henter; David A Luckenbaugh; Carlos A Zarate; Dennis S Charney
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014       Impact factor: 13.820

4.  Intact urothelial barrier function in a mouse model of ketamine-induced voiding dysfunction.

Authors:  Retnagowri Rajandram; Teng Aik Ong; Azad H A Razack; Bryce MacIver; Mark Zeidel; Weiqun Yu
Journal:  Am J Physiol Renal Physiol       Date:  2016-02-24

5.  Ketamine-induced ventricular structural, sympathetic and electrophysiological remodelling: pathological consequences and protective effects of metoprolol.

Authors:  Y Li; J Shi; B F Yang; L Liu; C L Han; W M Li; D L Dong; Z W Pan; G Z Liu; J Q Geng; L Sheng; X Y Tan; D H Sun; Z H Gong; Y T Gong
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 6.  Ketamine for chronic pain: risks and benefits.

Authors:  Marieke Niesters; Christian Martini; Albert Dahan
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

Review 7.  Alternative drugs of abuse.

Authors:  M E Sutter; J Chenoweth; T E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

8.  Chronic ketamine treatment-induced changes in contractility characteristics of the mouse detrusor.

Authors:  Hong Chai Tang; Wai Ping Lam; Xin Zhang; Ping-Chung Leung; David T Yew; Willmann Liang
Journal:  Int Urol Nephrol       Date:  2014-03-12       Impact factor: 2.370

9.  Ketamine Self-Administration Elevates αCaMKII Autophosphorylation in Mood and Reward-Related Brain Regions in Rats.

Authors:  Lucia Caffino; Alessandro Piva; Francesca Mottarlini; Marzia Di Chio; Giuseppe Giannotti; Cristiano Chiamulera; Fabio Fumagalli
Journal:  Mol Neurobiol       Date:  2017-09-25       Impact factor: 5.590

10.  Ketamine activates breathing and abolishes the coupling between loss of consciousness and upper airway dilator muscle dysfunction.

Authors:  Matthias Eikermann; Martina Grosse-Sundrup; Sebastian Zaremba; Mark E Henry; Edward A Bittner; Ulrike Hoffmann; Nancy L Chamberlin
Journal:  Anesthesiology       Date:  2012-01       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.